Organic Process Research & Development 2002, 6, 458−462
New Continuous Production Process for Enantiopure (2R,5R)-Hexanediol
Ju¨rgen Haberland,† Werner Hummel,‡ Thomas Daussmann,§ and Andreas Liese*,†
Institute of Biotechnology, Research Center Juelich GmbH, 52425 Juelich, Germany, Institute of Enzyme Technology,
Heinrich-Heine UniVersity of Duesseldorf, 52426 Juelich, Germany, and Juelich Fine Chemicals GmbH (JFC),
52428 Juelich, Germany
Abstract:
yield is only 30%.7 The second approach is the use of
oxazaborolidines in tetrahydrofurane as the solvent. At 75%
the described yields are moderate and only 45% ee was
reached.8,9 The third approach uses ruthenium-BINAP
complexes as catalysts for the reduction. The optical purities
seem to be moderate, but the yields are rather low 15-50%.10
Biotechnological approaches are not often found in the
literature, although they are used for production purposes.
The established industrial production process for (2R,5R)-
hexanediol is a multistep synthesis starting with an enantio-
selective acylation of the (R)-hydroxy function of the
racemic/meso (2,5)-hexanediol mixture catalyzed by a li-
pase.11,12 Subsequently, the nonacylated (S)-hydroxy function
of the meso-(R,S)-diol is inverted by chemical transformation
with methane sulfonyl chloride leading to the (R,R)-diol.
Reagents used in the production process are triethylamine,
methane sulfonyl chloride, dichloromethane, dimethyl for-
mamide, cesium acetate, methanol, and acidic resins (Am-
berlite IR 120). The maximum theoretical yield of this
process is 75%. However, no information has been published
on the real yields achieved in this process. Another microbial
approach using resting whole cells to produce (2R,5R)-
hexanediol was published by Ohta et al. in 1996.13 Pichia
farinosa is used as a biocatalyst to reduce (2,5)-hexanedione
to (2R,5R)-hexanediol. In batch experiments yields of about
83% are achieved. The enantiomeric excess is >99%, but
the diastereomeric excess is only >95%. The productivity
is very low in this process (12.5 mgproduct/gwetweight).
A new continuous production process has been developed for
optically active pure (2R,5R)-hexanediol. The process uses
resting whole cells of Lactobacillus kefir DSM 20587 as a
biocatalyst. The reduction of (2,5)-hexanedione to (2R,5R)-
hexanediol was carried out in a 2-L continuously operated
membrane reactor. Conversion of (2,5)-hexanedione was nearly
quantitative and the selectivity between product and intermedi-
ate was 78% for the product. Enantioselectivity and diastereo-
selectivity were >99% for the whole period. The productivity
of L. kefir could be increased by factor 30. (2R,5R)-Hexanediol
was continuously produced over 5 days with a space-time yield
of 64 g‚L-1‚d-1
.
Introduction
Enantio- and diastereomerically pure diols are important
and interesting building blocks for the synthesis of pharma-
ceuticals, agrochemicals, and fine chemicals.1 (2R,5R)-
Hexanediol is a versatile building block for the synthesis of
various chiral phosphine ligands, which are used in chiral
Wilkinson catalysts.2,3,4
Here we present the application of resting whole cells
from Lactobacillus kefir DSM 20587 as a biocatalyst5,6 for
the enantio- and diastereoselective reduction of (2,5)-
hexanedione 1 to (2R,5R)-hexanediol 3. The reaction is
shown in Figure 1. The respective enantio- and diastereo-
selectivities of the product were >99%.
In the literature there are several chemical routes published
leading to (2R,5R)-hexanediol. In principle only three dif-
ferent approaches are used. The first is the use of compounds
from the chiral pool to introduce chirality. D-Mannitol is a
possible starting compound. In a three-step reaction sequence
3 can be synthesized in high optical purities, but the overall
The production process introduced in this contribution
starts from a much cheaper substrate than that used industri-
ally, and in comparison to the whole-cell approach described
by Ohta et al. (see Continuous Reduction section) higher
productivities were achieved. Furthermore, the reduction with
L. kefir leads to quantitative optical purities. After extraction
with ethyl acetate and crystallization from isooctane the
product is isolated in its optically pure form. A further
Telephone: +49-2461-616044. Fax: +49-2461-613870.
† Institute of Biotechnology, Research Center.
(7) Saravanan, P.; Raina, S.; Sambamurthy, T.; Singh, V. K. J. Org. Chem.
1997, 62, 2669-2670.
(8) Bach, J.; Berenguer, R.; Garcia, J.; Loscertales, T.; Manzanal, J.; Vilarrasa,
J. Tetrahedron Lett. 1997, 38(6), 1091-1094.
(9) Bach, J.; Berenguer, R.; Garcia, J.; Lopez, M.; Manzanal, J.; Vilarrasa, J.
Tetrahedron 1998, 54, 14947-14962.
‡ Institute of Enzyme Technology, Heinrich-Heine University of Duesseldorf.
§ Juelich Fine Chemicals GmbH.
(1) Liese, A.; Seelbach, K.; Buchholz, A.; Haberland, J. Processes. In Industrial
Biotransformations; Liese, A., Seelbach, K., Wandrey, C., Eds.; Wiley-
VCH: Weinheim, 2000; pp 93-392.
(2) Burk, M. J.; Feaster, J. E.; Harlow, R. L. Organometallics 1990, 9, 2653-
2655.
(10) Fan, Q.-H.; Yeung, C.-H.; Chan, A. S. C. Tetrahedron: Asymmetry 1997,
8(24), 4041-4045.
(3) Burk, M. J. J. Am. Chem. Soc. 1991, 113, 8518-8519.
(4) Burk, M. J.; Feaster, J. E.; Harlow, R. L. Tetrahedron: Asymmetry 1991,
2(7), 569-592.
(5) Hummel, W.; Liese, A.; Wandrey, C. Process for Reducing Keto-Group
Containing Compounds. Eur. Patent 00113127.51-2110, 2000.
(6) Haberland, J.; Kriegesmann, A.; Wolfram, E.; Hummel, W.; Liese, A. Appl.
Microbiol. Biotechnol. 2002, 58, 595-599.
(11) Taylor, S. J. C.; Holt, K. E.; Brown, R. C.; Keene, P. A.; Taylor, I. N.
Choice of Biocatalyst in the Development of Industrial Biotransformations.
In StereoselectiVe Biocatalysis; Patel, R. N., Ed.; Marcel Dekker: New York,
2000; pp 397-404.
(12) Nagai, H.; Morimoto, T.; Achiwa, K. Synlett 1994, 4, 289-290.
(13) Ikeda, H.; Sako, E.; Sugai, T.; Ohta, H. Tetrahedron 1996, 52(24), 8113-
8122.
458
•
Vol. 6, No. 4, 2002 / Organic Process Research & Development
10.1021/op020023t CCC: $22.00 © 2002 American Chemical Society
Published on Web 06/08/2002